Health in Netherlands, The 1,121 indicators covering health for Netherlands, The. IndicatorLatest Year10-yr change Rank Most sold brand of cigarettes - taxes as a % of price - total tax 0.8% 2020 up 5.5% 31st Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.1% 2020 down 76.2% 95th Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 — 33rd Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 — 41st Most sold brand of cigarettes - taxes as a % of price - value added 0.2% 2020 up 6.2% 19th Most sold brand of cigarettes - taxes as a % of price - specific 0.6% 2020 up 52.8% 16th Most sold brand of cigarettes - price in US$ at official exchange 9.48 2020 up 44.1% 18th Number healthy diet unaffordable 200,000 2024 down 33.3% 119th Import of environmentally sound technologies 32.07 billion 2020 up 41.5% 9th Percentage of people living with HIV who know their HIV status 94 2024 up 6.8% 21st Percentage of people living with HIV who know their status receiving 95 2024 up 4.4% 39th Most sold brand of cigarettes - price in PPP$ 10.18 2020 up 71.7% 33rd Export of environmentally sound technologies 34.43 billion 2020 up 31.9% 6th Pcv3 number unvaccinated 21,814 2023 up 202.5% 72nd Infant mortality 512 2019 down 21.0% 9th Health risks - Regions — Respiratory system diseases mortality crude 84.83 Per 100 000 inhabitants 2024 up 36.6% 12th Health risks - Regions — Circulatory system diseases mortality crude 212.28 Per 100 000 inhabitants 2024 down 5.6% 26th Reported number of human rabies deaths 0 2023 down 100.0% 62nd Projected life expectancy by age (in completed years), sex and type 89.3 2100 up 0.9% 13th Assumptions for mortality rates by age, sex and type of projection 0.0023 2100 down 14.4% 10th Projected life expectancy by age, sex and type of projection 89 2100 up 1.3% 13th Assumptions for mortality rates by age, sex and type of projection 0.0003 2100 down 33.3% 10th Projected life expectancy by age (in completed years), sex and type 89.6 2100 up 1.0% 14th Life expectancy by age and sex 81.9 2024 up 0.4% 20th Number of non-autochthonous leprosy cases 2 2023 down 60.0% 29th Crude death rate hmd 9.48 2023 up 13.2% 23rd Births and deaths 9.48 2023 up 13.2% 23rd Period versus cohort life expectancy 81.84 2023 up 0.7% 21st Annual death rate by age group 3.6 2023 down 3.5% 17th Number reported cases of cholera 2 2020 down 60.0% 72nd HPV immunization coverage estimates among primary target cohort (9-14) 65.0% 2025 down 1.5% 73rd Life expectancy at birth oecd 81.4 2021 up 0.1% 20th How many health warnings are approved by the law for cigarette 15 2022 down 11.8% 11th Tuberculosis - new and relapse cases 970 2011 down 31.1% 122nd Number of reported cholera deaths 0 2016 — 37th Physiotherapists 33,544 2023 down 7.6% 13th Health graduates 2,574 2024 up 5.1% 8th Health personnel 71,184 2024 up 23.2% 8th Coverage of the human papillomavirus vaccine 65 2024 up 14.0% 37th Generalist medical practitioners 32,415 2023 up 32.3% 21st Percentage of principal display area mandated to be covered by health 65 2022 up 85.7% 25th Average of 13 International Health Regulations core capacity scores 94.6 2017 up 31.4% 28th New cases: pulmonary smear-negative 161 2012 down 44.7% 128th Estimated number of pregnant women living with HIV needing 100 2024 down 50.0% 79th Hospital beds by function and type of care 39,800 2024 down 33.4% 14th Percentage of principal display area mandated to be covered by health 65 2022 up 116.7% 26th Percentage of principal display area mandated to be covered by health 65 2022 up 62.5% 30th Total number of notified TB cases 823 2014 down 38.8% 125th The number of people with susceptibility test result for rifampicin 270 2021 — 88th Specialist medical practitioners 37,570 2023 up 20.5% 25th New cases: pulmonary smear unknown/not done 139 2012 down 39.8% 54th Smear-positive tuberculosis treatment-success rate 81.0% 2011 up 6.6% 92nd How many health warnings are approved by the law for other smoked 15 2022 down 11.8% 12th Insufficiently active 80.17 2016 down 0.2% 99th Percentage of principal display area mandated to be covered by health 65 2022 up 85.7% 22nd The number of people with susceptibility test result for rifampicin 86.26 2021 — 82nd Contraceptive prevalence, any method 68.0% 2013 up 3.0% 4th Percentage of principal display area mandated to be covered by health 65 2022 up 62.5% 24th Percentage of principal display area mandated to be covered by health 65 2022 up 116.7% 23rd Medical doctors 59.3% 2023 up 17.4% 25th ← Previous Page 17 of 19 Next →